Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://ghbwindowcleaning.com
Are you over 18 and want to see adult content?
A complete backup of https://airbnb.co.id
Are you over 18 and want to see adult content?
A complete backup of https://icy.com.cn
Are you over 18 and want to see adult content?
A complete backup of https://americanheadachesociety.org
Are you over 18 and want to see adult content?
A complete backup of https://geoffchappell.com
Are you over 18 and want to see adult content?
A complete backup of https://ridinghouse.cafe
Are you over 18 and want to see adult content?
A complete backup of https://bolton.ac.uk
Are you over 18 and want to see adult content?
A complete backup of https://mastercardbiz.com
Are you over 18 and want to see adult content?
A complete backup of https://goaheadafrica.net
Are you over 18 and want to see adult content?
A complete backup of https://ninja-official.com
Are you over 18 and want to see adult content?
A complete backup of https://sinarharapan.net
Are you over 18 and want to see adult content?
A complete backup of https://hansaavm.com
Are you over 18 and want to see adult content?
Favourite Annotations
Holiday Cottages To Rent - UK Cottage Holidays | Sykes Cottages
Are you over 18 and want to see adult content?
Business Loans, Line of Credit and Invoice Factoring | BlueVine
Are you over 18 and want to see adult content?
Moderne Carports und Garagen. Maßgeschneiderte Ideen ✓
Are you over 18 and want to see adult content?
مختبرات ﭬيشي: مستحضرات تجميل، منتجات للتجميل، منتجات للعناية بالوجه والجسم
Are you over 18 and want to see adult content?
Kshowsubindo.Web.Id - Download Drama Korea Terbaru
Are you over 18 and want to see adult content?
BEST Casting | Extras, Featured Extras, Stand Ins, Specialist & Skilled Extras
Are you over 18 and want to see adult content?
ゲーム推奨PCサイト ゲーミングPCをおすすめ! | ゲーム最新のPC スペックとおすすめパソコンを安いノートからデスクトップまでご紹介。BTO ゲームPCの選び方も解説。
Are you over 18 and want to see adult content?
CAP 1 QUE ES LA MACROECONOMIA
Are you over 18 and want to see adult content?
Text
ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events.PATIENT SUPPORT
Patient Support. Take a look below at our patient support material which can be downloaded and information about patient support groups. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Charities and Organisations. Patient Apps.LIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK. YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
ALL THINGS DR FALK: TOGETHER IN ONE PLACE All things Dr Falk: Together in one place An app for digestive and metabolic disease healthcare professionals to promote collaboration and shared learning, by bringing INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’s DR FALKABOUTPATIENTSHCPMEDIACONTACTDISEASES & TREATMENTS release when – and only when – they’ve arrived where they’re needed most. At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. It’s a simple formula. We call it the Dr Falk way.ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events.PATIENT SUPPORT
Patient Support. Take a look below at our patient support material which can be downloaded and information about patient support groups. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Charities and Organisations. Patient Apps.LIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK. YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
ALL THINGS DR FALK: TOGETHER IN ONE PLACE All things Dr Falk: Together in one place An app for digestive and metabolic disease healthcare professionals to promote collaboration and shared learning, by bringing INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’sWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. DISEASES & TREATMENTS The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis, Autoimmune Hepatitis and Primary Sclerosing Cholangitis. These diseases have chronic clinical courses and if left untreated can leadto serious
PHARMACIST MEETINGS SERIES The sessions aim to build on the Pharmacist’s knowledge as a series but can also be accessed as individual modules of particular interest. All meetings will be online from 6pm – 7.30pm. 29th April – Effective Collaboration in IBD Care and COVID-19: Shared Approaches from Primary and Secondary Care. 29th June – A&P of the GI Tract in WANT TO GET IN CONTACT? In the first place, tell your doctor, nurse or pharmacist about it and ask them to report it using the Yellow Card (UK) or report to the Health Products Regulatory Authority (IE). Alternatively, contact us at office@drfalkpharma.co.uk or call the Medical Director on 07765 004275 or the Regulatory Manager on 07765 403015 and we will make thereport.
LIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
DR FALK RESEARCH & DEVELOPMENT Our Capabilities. In product formulation Dr Falk Pharma has special competence in the development of topical delivery systems for diseases of the intestinal tract, which has resulted in a range of patents and approvals. The project management team in clinical research is highly experienced in the organisation of multi-centre studies required DR FALK AWARDS IRELAND Awards 2020. We are delighted to announce the winners of the first Dr Falk Ireland SpR and IBD Nurse Awards. The winners, SpRs Dr Ciaran Judge, Dr Clodagh Murphy and IBD Nurses Mary Hamzawi and Emma Anderson, were formally notified at the IBD Nurses Association of Ireland (IBDNAI) virtual meeting in November, by gastroenterologist DrAoibhlinn
CHARITIES AND ORGANISATIONS Register. Please fill out your details below to register for our site for healthcare professionals. COLLABORATION. FORMULATION. DESTINATION. RECOGNISING At Dr Falk, we believe exchanging knowledge is a key factor to advancing treatments. Over the past 60 years, we’ve built a wealth of resources to spark MEDICAL CAUSES OF CHRONIC DIARRHOEA The informed patient MEDICAL CAUSES OF CHRONIC DIARRHOEA 14130_DF_IBS_Booklet.indd 1 27/05/2015 11:11 DR FALKABOUTPATIENTSHCPMEDIACONTACTDISEASES & TREATMENTS release when – and only when – they’ve arrived where they’re needed most. At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. It’s a simple formula. We call it the Dr Falk way.ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events. DISEASES & TREATMENTS The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis, Autoimmune Hepatitis and Primary Sclerosing Cholangitis. These diseases have chronic clinical courses and if left untreated can leadto serious
DR FALK RESEARCH & DEVELOPMENT Our Capabilities. In product formulation Dr Falk Pharma has special competence in the development of topical delivery systems for diseases of the intestinal tract, which has resulted in a range of patents and approvals. The project management team in clinical research is highly experienced in the organisation of multi-centre studies requiredLIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK. YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’s DR FALKABOUTPATIENTSHCPMEDIACONTACTDISEASES & TREATMENTS release when – and only when – they’ve arrived where they’re needed most. At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. It’s a simple formula. We call it the Dr Falk way.ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events. DISEASES & TREATMENTS The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis, Autoimmune Hepatitis and Primary Sclerosing Cholangitis. These diseases have chronic clinical courses and if left untreated can leadto serious
DR FALK RESEARCH & DEVELOPMENT Our Capabilities. In product formulation Dr Falk Pharma has special competence in the development of topical delivery systems for diseases of the intestinal tract, which has resulted in a range of patents and approvals. The project management team in clinical research is highly experienced in the organisation of multi-centre studies requiredLIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK. YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’sWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. DR FALK RESEARCH & DEVELOPMENT Our Capabilities. In product formulation Dr Falk Pharma has special competence in the development of topical delivery systems for diseases of the intestinal tract, which has resulted in a range of patents and approvals. The project management team in clinical research is highly experienced in the organisation of multi-centre studies required WANT TO GET IN CONTACT? In the first place, tell your doctor, nurse or pharmacist about it and ask them to report it using the Yellow Card (UK) or report to the Health Products Regulatory Authority (IE). Alternatively, contact us at office@drfalkpharma.co.uk or call the Medical Director on 07765 004275 or the Regulatory Manager on 07765 403015 and we will make thereport.
PATIENT SUPPORT
Patient Support. Take a look below at our patient support material which can be downloaded and information about patient support groups. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Charities and Organisations. Patient Apps. PHARMACIST MEETINGS SERIES The sessions aim to build on the Pharmacist’s knowledge as a series but can also be accessed as individual modules of particular interest. All meetings will be online from 6pm – 7.30pm. 29th April – Effective Collaboration in IBD Care and COVID-19: Shared Approaches from Primary and Secondary Care. 29th June – A&P of the GI Tract in CHARITIES AND ORGANISATIONS Register. Please fill out your details below to register for our site for healthcare professionals. DR FALK AWARDS IRELAND Awards 2020. We are delighted to announce the winners of the first Dr Falk Ireland SpR and IBD Nurse Awards. The winners, SpRs Dr Ciaran Judge, Dr Clodagh Murphy and IBD Nurses Mary Hamzawi and Emma Anderson, were formally notified at the IBD Nurses Association of Ireland (IBDNAI) virtual meeting in November, by gastroenterologist DrAoibhlinn
ALL THINGS DR FALK: TOGETHER IN ONE PLACE All things Dr Falk: Together in one place An app for digestive and metabolic disease healthcare professionals to promote collaboration and shared learning, by bringing METHODOLOGICAL NOTES 2015 Methodological Notes The pharmaceutical industry in the United Kingdom is committed to benefiting patients by operating in a professional, ethical and transparent manner to ensure the appropriate use of medicines and support the provision of high quality ORAL BUDESONIDE IN GASTROINTESTINAL AND LIVER DISEASE: A REVIEW Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician Stephan Miehlke,* Manuel Barreiro-de Acosta,† Gerd Bouma,‡ Daniel Carpio,§ Fernando Magro,¶,** Tom Moreels†† and Chris Probert‡‡ *Center for Digestive Diseases, Internal Medicine Center Eppendorf, Hamburg, Germany; and †Intestinal Inflammatory Disease Unit, Department of DR FALKABOUTPATIENTSHCPMEDIACONTACTDISEASES & TREATMENTS release when – and only when – they’ve arrived where they’re needed most. At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. It’s a simple formula. We call it the Dr Falk way.ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events.PATIENT SUPPORT
Patient Support. Take a look below at our patient support material which can be downloaded and information about patient support groups. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Charities and Organisations. Patient Apps. ALL THINGS DR FALK: TOGETHER IN ONE PLACE All things Dr Falk: Together in one place An app for digestive and metabolic disease healthcare professionals to promote collaboration and shared learning, by bringingLIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’s EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK. DR FALKABOUTPATIENTSHCPMEDIACONTACTDISEASES & TREATMENTS release when – and only when – they’ve arrived where they’re needed most. At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. It’s a simple formula. We call it the Dr Falk way.ABOUT DR FALK
Dr Falk Pharma UK was set up in 2005 to provide the Falk organisation with its own presence in the UK and Ireland. Our parent company, Dr Falk Pharma GmbH is an independent family firm based in Freiburg, Germany. Guided by the Falk philosophy, Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding andWELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. HEALTHCARE PROFESSIONALS Events. For almost 40 years Dr Falk Pharma have provided doctors with a platform for the exchange of knowledge in both pure and clinical research at the highest international level but also at regional or local levels. Visit one of our events.PATIENT SUPPORT
Patient Support. Take a look below at our patient support material which can be downloaded and information about patient support groups. Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Charities and Organisations. Patient Apps. ALL THINGS DR FALK: TOGETHER IN ONE PLACE All things Dr Falk: Together in one place An app for digestive and metabolic disease healthcare professionals to promote collaboration and shared learning, by bringingLIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
YOU•••TRACK SMARTPHONE APP you•••track uses a tool called the Simple Clinical Colitis Activity Index (SCCAI – also called the Walmsley index). This is a symptom measuring system that has been used to monitor UC disease activity for many years in clinical studies. Adapted for use on a smartphone, it will take you less than a minute each day to keep anaccurate
INFLAMMATORY BOWEL DISEASES The exact cause of inflammatory bowel diseases (IBD) remains unknown. It is probable that these diseases are not due to a single cause and it is believed that the inflammation is triggered by a combination of different factors. For example, hereditary factors appear to play a key role. Although neither ulcerative colitis (UC) nor Crohn’s EOSINOPHILIC OESOPHAGITIS (EOE) The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards and how to enter. Dr Falk/Guts UK.WELCOME – DR FALK
Acrobat Reader. The following pages contain some links allowing you to look at or download information files in pdf format. The “Adobe Acrobat Reader” program needed to view these files is available free on the internet. Simply click below which will take you to Adobe, and you can install the program on your computer from there. DISEASES & TREATMENTS The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis, Autoimmune Hepatitis and Primary Sclerosing Cholangitis. These diseases have chronic clinical courses and if left untreated can leadto serious
LIVER DISEASES
Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that predominantly affects men aged 25 to 40 years. It is characterised by inflammation of the bile ducts that leads to narrowing (stenosis) with accumulation of the bile in the liver (cholestasis). The bile, which also contains aggressive bileacids
DR FALK RESEARCH & DEVELOPMENT Our Capabilities. In product formulation Dr Falk Pharma has special competence in the development of topical delivery systems for diseases of the intestinal tract, which has resulted in a range of patents and approvals. The project management team in clinical research is highly experienced in the organisation of multi-centre studies required WANT TO GET IN CONTACT? In the first place, tell your doctor, nurse or pharmacist about it and ask them to report it using the Yellow Card (UK) or report to the Health Products Regulatory Authority (IE). Alternatively, contact us at office@drfalkpharma.co.uk or call the Medical Director on 07765 004275 or the Regulatory Manager on 07765 403015 and we will make thereport.
PHARMACIST MEETINGS SERIES The sessions aim to build on the Pharmacist’s knowledge as a series but can also be accessed as individual modules of particular interest. All meetings will be online from 6pm – 7.30pm. 29th April – Effective Collaboration in IBD Care and COVID-19: Shared Approaches from Primary and Secondary Care. 29th June – A&P of the GI Tract in DR FALK AWARDS IRELAND Awards 2020. We are delighted to announce the winners of the first Dr Falk Ireland SpR and IBD Nurse Awards. The winners, SpRs Dr Ciaran Judge, Dr Clodagh Murphy and IBD Nurses Mary Hamzawi and Emma Anderson, were formally notified at the IBD Nurses Association of Ireland (IBDNAI) virtual meeting in November, by gastroenterologist DrAoibhlinn
CHARITIES AND ORGANISATIONS Register. Please fill out your details below to register for our site for healthcare professionals. MEDICAL CAUSES OF CHRONIC DIARRHOEA The informed patient MEDICAL CAUSES OF CHRONIC DIARRHOEA 14130_DF_IBS_Booklet.indd 1 27/05/2015 11:11 ORAL BUDESONIDE IN GASTROINTESTINAL AND LIVER DISEASE: A REVIEW Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician Stephan Miehlke,* Manuel Barreiro-de Acosta,† Gerd Bouma,‡ Daniel Carpio,§ Fernando Magro,¶,** Tom Moreels†† and Chris Probert‡‡ *Center for Digestive Diseases, Internal Medicine Center Eppendorf, Hamburg, Germany; and †Intestinal Inflammatory Disease Unit, Department ofSkip to content
Dr Falk
__
* About
* Overview
* Charities and Organisations * Dr Falk Research & Development* Patients
* Overview
* Diseases & Treatments* Patient Support
* HCP
* Overview
* Educational & Clinical Resources* Events
* Products
* Dr Falk/Guts UK Awards * Dr Falk Awards Ireland* Media
* Contact
Login Register
Search for: __
FOR US, EVERY TREATMENT IS A JOURNEY*
Falk Awards UK
Our 2020 Awards winners acknowledged in a virtual event View winning projects here >*
NEW: FalkPlus
Our new community app available to download nowClick here >
*
FalkPlus
Our new community app Watch a short video to learn more >*
Falk Awards Ireland
The 2021 Awards are now open for entries until 31/10/2021 Click her for details >*
BSG Campus 2021
Professor Stephen Attwood's update on EoE View video recording here >*
BSG Campus 2021
Dr Roger Chapman's update on AIH View video recording here >*
Pharmacist Meetings
UKCPA Gastroenterology online webinar series Click here to register >DESTINATION:
INTESTINAL VILLUS
COLLABORATION
FORMULATION
DESTINATION
The more that patients know about their treatment, the more they getout of it.
The more clinicians and researchers understand patients’ needs, the better they can address them. If it’s important to patients, it’s important to us. By offering patients a range of formulations, they can not only make the choice most suited to them, but also share ownership of theirtreatment journey.
When a disease is defined by its whereabouts, its treatment should betoo.
That’s why we go to great lengths to help make sure our treatments release when – and only when – they’ve arrived where they’reneeded most.
At Dr Falk, we do things differently. Our focus isn’t just on diseases, it’s on people, so for every treatment we develop, whether for gastroenterology or liver disease, we do it our way. IT’S A SIMPLE FORMULA. WE CALL IT THE DR FALK WAY.UPCOMING EVENTS
Choose Event Falk Forums Falk Futures Meetings Gastro Meetings Liver Series Meetings Nurse Education Meetings Other Meetings Pharmacist Series Meetings SpR Meetings Symposia TRANSITION IN IBD - WEDNESDAY 9TH JUNE 2021 Dear Colleague, Dr Falk Pharma would like to invite you to join this educational meeting developed for all Health Care Professional's with an interest in Gastroenterology. This meeting is part of 'The Dr Falk Gastro Meeting Series' which aim to bring you a range of topics delivered by key speakers and chairs. We are ... Continue ReadingLocation: Virtual
Date: Wednesday, 9 Jun 2021 View Event > PBC AND AIH: CURRENT MANAGEMENT CHALLENGES - THURSDAY 17TH JUNE 2021 Dear Colleagues We would like to welcome you to the Falk 60th Anniversary Celebration Seminar Series. The Falk Foundation have now been supporting educational activity in liver and GI disease for 60 years, supporting young and established investigators form around the world to come together to share and develop ideas in liver ...Continue Reading
Location: Virtual
Date: Thursday, 17 Jun 2021 View Event > GORD – HOW TO DISTINGUISH IT FROM EOE? - TUESDAY 22ND JUNE 2021 Dear Colleague, Dr Falk Pharma would like to invite you to join this educational meeting developed for all Health Care Professional's with an interest in Gastroenterology. This meeting is part of 'The Dr Falk Gastro Meeting Series' which aim to bring you a range of topics delivered by key speakers and chairs. We are ... Continue ReadingLocation: Virtual
Date: Tuesday, 22 Jun 2021 View Event > A&P OF THE GI TRACT IN HEALTH AND GASTROINTESTINAL DISEASE - WEBINAR 3- 29TH JUNE 2021
Dear Colleagues The Dr Falk – UKCPA Gastroenterology Webinar Series consists of four webinars which will give the Pharmacist an overview of different aspects of gastroenterology in health and disease, specifically focusing on Inflammatory Bowel Diseases (IBD) and the effect of disease and surgery on drug delivery and metabolism. The practical management ... Continue ReadingLocation:
Date: Tuesday, 29 Jun 2021 View Event > A&P OF THE GI TRACT IN HEALTH AND GASTROINTESTINAL DISEASE - WEBINAR 3- 29TH JUNE 2021
Dear Colleagues The Dr Falk – UKCPA Gastroenterology Webinar Series consists of four webinars which will give the Pharmacist an overview of different aspects of gastroenterology in health and disease, specifically focusing on Inflammatory Bowel Diseases (IBD) and the effect of disease and surgery on drug delivery and metabolism. The practical management ... Continue ReadingLocation:
Date: Tuesday, 29 Jun 2021 View Event > PHARMACOKINETICS OF ORALLY ADMINISTERED MEDICATIONS IN GASTROINTESTINAL DISEASE - WEBINAR 4 - 13TH JULY 2021 Dear Colleagues The Dr Falk – UKCPA Gastroenterology Webinar Series consists of four webinars which will give the Pharmacist an overview of different aspects of gastroenterology in health and disease, specifically focusing on Inflammatory Bowel Diseases (IBD) and the effect of disease and surgery on drug delivery and metabolism. The practical management ... Continue ReadingLocation:
Date: Tuesday, 13 Jul 2021 View Event > PHARMACOKINETICS OF ORALLY ADMINISTERED MEDICATIONS IN GASTROINTESTINAL DISEASE - WEBINAR 4 - 13TH JULY 2021 Dear Colleagues The Dr Falk – UKCPA Gastroenterology Webinar Series consists of four webinars which will give the Pharmacist an overview of different aspects of gastroenterology in health and disease, specifically focusing on Inflammatory Bowel Diseases (IBD) and the effect of disease and surgery on drug delivery and metabolism. The practical management ... Continue ReadingLocation:
Date: Tuesday, 13 Jul 2021 View Event > ENDOSCOPIC EVALUATION OF BILIARY STRICTURES IN PSC/IGG4 DISEASE - THURSDAY 2ND SEPTEMBER 2021 Dear Colleagues We would like to welcome you to the Falk 60th Anniversary Celebration Seminar Series. The Falk Foundation have now been supporting educational activity in liver and GI disease for 60 years, supporting young and established investigators form around the world to come together to share and develop ideas in liver ...Continue Reading
Location: Virtual
Date: Thursday, 2 Sep 2021 View Event > FALK FORUM 83 BIRMINGHAM - IBD 2021 AND BEYOND - FRIDAY 10TH SEPTEMBER2021
Dear Colleagues It is a great pleasure to welcome you to our Falk Forum Webinar entitled IBD 2021 and Beyond. Inflammatory bowel disease is a rapidly developing field that crosses all our paths in our clinics and wards. Now add Covid 19 to the mix. The rapidly evolving range of therapies, dietary needs and ... Continue ReadingLocation: Virtual
Date: Friday, 10 Sep 2021 View Event >See all events
AWARDS
The Dr Falk/Guts UK Awards were launched in 2007. Find out more about the Awards; view the previous winners, read summaries of their research and find out about this year’s Dr Falk/Guts UK Awards andhow to enter.
Dr Falk/Guts UK
PRODUCTS
Comprehensive information on the Dr Falk Pharma product range can be found here (products licensed in the UK and Ireland).Find out more
PATIENT SUPPORT
Dr Falk patient support items are available to view or order fromhere.
Search patient support Dr Falk Pharma UK Ltd, Unit K, Bourne End Business Park, Cores End Rd,Bourne End, SL8 5AS
* Contact
* Cookie and Privacy Policy * Terms & Conditions Tel: +44 (0)1628 53 66 00 Fax: +44 (0)1628 53 66 01 email: office@drfalkpharma.co.uk Username or Email AddressPassword
Remember Me
* Forgot password?
-------------------------Register
Please note that our privacy policy has recently been updated. Click here to review the policy.×
×
REGISTER
Please fill out your details below to register for our site for healthcare professionals. Preferred Email Address Please specify your preferred contact emailaddress
Password Please specify your password, which should be a minimum of 8 characters, including at least one number and one capital letter Confirm Password Passwords do not match ------------------------- Salutation Mr Mrs Miss Ms Dr Prof Please specify your salutation First Name Please specify your name Last Name Please specify your last name Position * Administrator Doctor GP Nurse Other Pharmacist Researcher Surgeon Please specify your position Main Area of Interest * Gastroenterology Liver Other Please specifyyour interest
Institution * Aberdeen Royal Infirmary Addenbrookes Hospital Aintree University Hospital Airedale General Hospital Alder Hey Children's Hospital & NHS Foundation TRust Alexandra Hospital Altnagelvin Area Hospital Antrim Hospital Arrowe Park Hospital Ashford Hospital Barking Hospital Barnet Hospital Barnsley District General Hospital Barringtons Hospital, Limerick Basildon Hospital Basingstoke and North Hampshire Hospital Bassetlaw District General Hospital Battle Hospital Beacon Hospital Beaumont Hospital Bedford Hospital Belfast City Hospital Birmingham Children's Hospital Bishop Auckland General Hospital Blackrock Clinic Bon Secours Hospital Cork Bon Secours Hospital Galway Bon Secours Hospital Glasnevin Bon Secours Hospital Tralee Borders General Hospital Bourne End Hospital Bradford Royal Infirmary Braintree Community Hospital Brecon Memorial Hospital Bristol Royal Infirmary Bronglais General Hospital Broomfield Hospital Bupa Hospital Norwich Burnley General Hospital Cahercalla Community Hospital Calderdale Royal Hospital Castle Hill Hospital Causeway Hospital Cavan General Hospital Central Middlesex Hospital Charing Cross Hospital Chase Farm Hospital Chelsea and Westminster Hospital Cheltenham General Hospital Chesterfield & North Derbyshire Royal Hospital Chorley & South Ribble Hospital Christie Hospital City General Hospital City Hospital Clane Hospital Colchester General Hospital Connolly Hospital Conquest Hospital Cork University Hospital Countess of Chester Hospital Countess of Chester Hospital County Hospital Craigavon Area Hospital Crawley Hospital Croydon University Hospital Cumberland Infirmary Daisy Hill Hospital Darent Valley Hospital Darlington Memorial Hospital Derbyshire Royal Infirmary Derriford Hospital Dewsbury & District Hospital Diana, Princess of Wales Hospital Doncaster Royal Infirmary Dorset County Hospital Downe Hospital Dr Renwick & Partners Dumfries & Galloway Royal Infirmary Ealing Hospital East Kent Hospital East Midlands SHA East Surrey Hospital Eastbourne General Hospital Ennis General Hospital, Co Clare Epsom General Hospital Fairfield General Hospital Forth Valley Royal Hospital Freeman Hospital Friarage Hospital Frimley Park Hospital Furness General Hospital Galway Clinic Gartnavel General Hospital George Eliot Hospital Glan Clwyd Hospital Glangwilli Hospital Glasgow Royal Infirmary Glenfield Hospital Gloucestershire Royal Hospital Good Hope Hospital Grantham Hospital Great Ormond Street Children's Hospital Grimsby District Hospital Guy's Hospital Hairmyres Hospital Hammersmith Hospital Harold Wood Hospital Harrogate District Hospital Haydock Medical Centre Health Centre, Mullingar Heartland Hospital Heatherwood Hospital Hemel Hempstead General Hospital Hendenway Surgery Hereford County Hospital Hexham Hospital Hillingdon Hospital Hinchingbrooke Hospital Homerton Hospital Horton Hospital Hospital of St Cross Huddersfield Royal Infirmary Hull Royal Infirmary Inverclyde Royal Hospital Ipswich Hospital James Cook University Hospital James Paget Hospital Janssen Pharmaceuticals Jersey General Hospital John Radcliffe Hospital Kent & Canterbury Hospital Kettering General Hospital Kidderminster Hospital King George Hospital Kings College Hospital Kings Mill Hospital Kingston Hospital Lagan Valley Hospital Leeds General Infirmary Leicester General Hospital Leicester PCT Leicester Royal Infirmary Leigh Infirmary Leighton Hospital Letterkenny University Hospital Lincoln County Hospital Lister Hospital Llandough Hospital Llandudno General Hospital Llwynpia Surgery London School of Hygiene & Tropical Medicine Lorn & Islands Hospital Louth County Hospital Luton & Dunstable Hospital Lymington New Forest Hospital Macclesfield District General Hospital Maidstone Hospital Mallow General Hospital Manchester Childrens' Hospital Manchester Royal Infirmary Mater Hospital Trust Mater Infirmorum Hospital Mater Misericordaie Hospital Mater Private Hospital Cork Mater Private Hospital Dublin Mayo University Hospital Medway Maritime Hospital Mercy University Hospital Mid Western Regional Hospital Midland Regional Hospital Mullingar Midland Regional Hospital Tullamore Midland Regional Hospital, Portladise Milford Hospital Millway Medical Practice Milton Keynes General Hospital Monaghan General Monklands District General Hospital Morriston Hospital Moseley Hall Hospital Musgrove Park Hospital Naas General Hospital Neath Port Talbot Hospital Nelson Hospital Nevill Hall Hospital New Cross Hospital Newark Hospital Newham University Hospital Ninewells Hospital & Medical School Norfolk & Norwich University Hospital North Devon District Hospital North Manchester General Hospital North Middlesex University Hospital North Tyneside General Hospital Northampton General Hospital Northern General Hospital Northwick Park Hospital Nottingham City Hospital Nottingham NHS Treatment Centre Nottingham Nuffield Hospital Ormskirk & District General Hospital Our Lady's Hospital Our Lady's Hospital for Sick Children Our Lady of Lourdes Hospital Perth Royal Infirmary Peterborough City Hospital Pilgrim Hospital Pinderfields General Hospital Pontefract General Infirmary Poole General Hospital Portiuncula University Hospital Prince Charles Hospital Prince Philip Hospital Princess Alexandra Hospital Princess of Wales Hospital Princess Royal Hospital Princess Royal Hospital - Telford Princess Royal University Hospital Queen's Hospital Burton Queen Alexandra Hospital Queen Elizabeth Hospital - Birmingham Queen Elizabeth Hospital - Gateshead Queen Elizabeth Hospital - London Queen Elizabeth II Hospital Queen Elizabeth The Queen Mother Hospital Queen Elizabeth University Hospital Queen Margaret Hospital Queen Mary's Hospital Queen Mary's Hospital - Sidcup Queens Hospital, Essex Queens Medical Centre Nottingham Raigmore Hospital Rochdale Infirmary Rotherham District General Hospital Royal Albert Edward Infirmary Royal Alexandra Children's Hospital Royal Alexandra Hospital Royal Berkshire Hospital Royal Blackburn Hospital Royal Bolton Hospital Royal Bournemouth Hospital Royal Cornwall Hospital Royal Derby Hospital Royal Devon & Exeter Hospital - Wonford Royal Free Hospital Royal Glamorgan Hospital Royal Gwent Hospital Royal Hallamshire Hospital Royal Hampshire County Hospital Royal Hospital Haslar Royal Infirmary of Edinburgh Royal Lancaster Infirmary Royal Liverpool University Hospital Royal London Hospital Royal Marsden Hospital Royal Oldham Hospital Royal Preston Hospital Royal Shrewsbury Hospital Royal Stoke University Hospital Royal Surrey County Hospital Royal Sussex County Hospital Royal United Hospital Royal Victoria Hospital Royal Victoria Infirmary Russells Hall Hospital Salford Royal Hospital Salisbury District Hospital Sandwell General Hospital Scarborough General Hospital Scunthorpe General Hospital Selly Oak Hospital Shanakiel Hospital Sheffield CCG Sheffield Childrens Hospital Sheffield Teaching Hospital Singleton Hospital Sligo University Hospital Solihull Hospital South Tipperary General Hospital South Tyneside District Hospital South West Acute Hospital Southampton General Hospital Southend University Hospital Southmead Hospital Southport District General Hospital St Albans City Hospital St Andrews Medical Centre St Bartholomews Hospital St Columcille Hospital St George's Hospital St Helier Hospital St James Hospital, Dublin St James University Hospital St Johns Hospital at Howden St Johns Hospital Limerick St Joseph's Hospital St Joseph's Hospital Newport St Luke's General Hospital Kilkenny St Marks Hospital St Mary's Hospital - IOW St Mary's Hospital - London St Peters Hospital St Richards Hospital St Thomas' Hospital St Vincent's Private Hospital St Vincents University Hospital Staffordshire General Hospital Stepping Hill Hospital Stobhill General Hospital Stoke Mandeville Hospital Sunderland Royal Hospital Tallaght Hospital Tameside General Hospital Taunton & Somerset Hospital The Alexandra Hospital BMI The Great Western Hospital The London Clinic Main Hospital The Queen Elizabeth Hospital The Royal Hospital for Children and Young People Edinburgh. Torbay Hospital Trafford General Hospital Tralee General Hospital,Tralee Trinity College Dublin Tunbridge Wells Hospital Ulster Hospital University College London Hospital University Hospital Ayr University Hospital Coventry University Hospital Crosshouse University Hospital Galway University Hospital Lewisham University Hospital Lewisham University Hospital Limerick University Hospital of Hartlepool University Hospital of North Durham University Hospital of North Tees University Hospital of South Manchester University Hospital of Wales University Hospital Waterford University of Cambridge Vale of Leven District General Hospital Victoria Hospital - Blackpool Victoria Hospital - Kirkcaldy Victoria Infirmary Walsall Manor Hospital Walsgrave Hospital Wansbeck General Hospital Warrington Hospital Warwick Hospital Watford General Hospital West Cumberland Hospital West Middlesex University Hospital West Suffolk Hospital Western General Hospital Western Infirmary Weston General Hospital Wexford General Hospital Wexham Park Hospital Whipps Cross University Hospital Whiston Hospital Whiteabbey Hospital Whitfield Clinic Whittington Hospital Willesden Centre for Health and Care William Harvey Hospital Wishaw General Hospital Withybush General Hospital Worcestershire Royal Hospital Worthing Hospital Wrexham Maelor Hospital Wycombe Hospital Wythenshawe Hospital Yeovil District Hospital York Hospital Ysbyty Gwynedd Ysbyty Ystrad Fawr Please specify your institution Post Code Please enter a post code Look up Post Code not found Practice Name Please specify your practice name Practice Address 1 Please specify your practice addressPractice Address 2
Practice Town Please specify your practice townPractice County
Practice Post Code Please specify your practice post code Mobile +44+353 Please specify a valid mobile number +44+353 Alternate tel number Please specify a valid number I am a UK/Ireland registered healthcare professional Please confirm you are a UK/Ireland HCP Please review the Dr Falk Pharma UK Ltd Privacy Policybefore registering.
Receive Dr Falk Disease and Therapy Updates Receive Information about Dr Falk Meetings and Events We assure you that we work hard to keep your personal data secure and will not share any details with a 3rd party without your explicitconsent.
You will be given the opportunity to unsubscribe during everycommunication.
You can update your preference at any time by contacting privacy@drfalkpharma.co.uk.Cancel
DUE TO COVID-19 RESTRICTIONS DR FALK MEDICAL LIAISON TEAM IS STILL UNABLE TO VISIT HOSPITALS. HOWEVER, OUR PATIENT AND HCP SUPPORT MATERIALS ARE AVAILABLE EITHER TO VIEW OR DOWNLOAD FOR FREE FROM THE WEBSITE AT HTTPS://WWW.DRFALK.CO.UK/PATIENTS/PATIENT-SUPPORT/OR
HTTPS://WWW.DRFALK.CO.UK/HCP/EDUCATIONAL-AND-CLINICAL-RESOURCES/ THESE ITEMS CAN ALSO BE REQUESTED VIA EMAIL FROM OUR OFFICE ON OFFICE@DRFALKPHARMA.CO.UK OR BY TELEPHONING 01628 536 600 OR 07801 575875.
You may also be aware that Dr Falk have now launched Falkplus, our new app which will be used as an exclusive platform for live streamingof Dr Falk events.
To be able to join future Dr Falk meetings it is VERY IMPORTANT YOU TAKE THE FOLLOWING ACTIONS AND DOWNLOAD THE FALKPLUS APP. * DOWNLOAD FALKPLUS by following the link HTTPS://INSTALL.EVENTS/FALKPLUS. * Type in your email address and tap confirm * Check your inbox with your device – you’ll receive an email with a code and a link to activate your account. If you do not receive the email please check your spam folder * The same steps are to be followed to access the app on mobile devices and computers. We recommend that you save the link on your desk top computers for easy access in futur*
* PLEASE CONTACT YOUR LOCAL DR FALK REPRESENTATIVE OR EMAIL FALKPLUS@DRFALKPHARMA.CO.UK FOR FURTHER HELP OR CLICK ON THE ATTACHEDLINK.
* HTTPS://WWW.DRFALK.CO.UK/WP-CONTENT/UPLOADS/2021/05/FALKPLUS-DOWNLOAD-INSTRUCTIONS-LEAFLET-FINAL.PDF×
www.drfalk.co.uk uses cookies to improve user experience and allow functionality of the website, see our cookie policy. If you agree,
then cookies will be used. If you disagree, then cookies won’t be used but the website may not function efficiently for you. I agree Idisagree
You are now leaving www.drfalk.co.uk for an external website. Dr Falk Pharma UK accepts no responsibility for the content of other websites.Continue Cancel
×
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0